What Did the Study or Report Find?

The authors of a new commentary argue that treating major depressive disorder during pregnancy deserves equal priority in the conversation, not a secondary role behind medication caution. Once the effects of depression itself are separated from the effects of the medication used to treat it, the authors write, accumulated evidence points to little or no serious risk from SSRIs for most pregnancies. Their framework asks clinicians and patients to weigh three things together: the danger of leaving depression untreated, the benefit of treatment, and the potential risk of SSRI exposure — cautioning that dropping any one of the three distorts the picture.

Why Does This Matter?

Many pregnant patients and clinicians face uncertainty about whether to start, continue, or stop antidepressant treatment during pregnancy. Untreated depression during pregnancy is itself associated with risks, including impacts on prenatal care engagement, nutrition, and postpartum functioning. This commentary is aimed at helping structure that conversation around the full picture rather than medication risk alone.

When Should Someone Seek Professional Help?

Routine Appointment: Ongoing mild depressive symptoms during pregnancy should be discussed at a regular prenatal or mental health visit. Contact a Healthcare Professional Soon: Worsening mood, loss of interest, or difficulty functioning warrants a prompt conversation with an OB-GYN or psychiatric provider. Emergency: Thoughts of self-harm or harming the pregnancy require immediate attention — call 911 or go to the nearest emergency room.

How to Explain This to Your Doctor

It helps to describe when depressive symptoms started relative to the pregnancy, whether they existed before pregnancy, how they affect daily functioning and prenatal care, current or past antidepressant use, and any prior response to treatment.

Example of What a Patient Could Say

“I was diagnosed with depression before I became pregnant and I'm currently taking an SSRI. I'm now 14 weeks along and want to talk through whether to continue, adjust, or change my treatment given the pregnancy.”

Which Healthcare Professional May Help?

An OB-GYN, primary care physician, or psychiatrist can all be appropriate starting points; ideally, prenatal and mental health providers coordinate on this decision together.

Questions to Ask Your Doctor

• What are the risks of continuing my current medication during pregnancy?
• What are the risks of stopping or tapering it?
• How would untreated depression affect my pregnancy and postpartum recovery?
• Are there non-medication treatments that could be used alongside or instead?
• How will we monitor both my mental health and the pregnancy going forward?

What This Research Does NOT Prove

This is an expert commentary synthesizing existing evidence, not a new clinical trial. It does not establish that SSRIs are risk-free for every pregnancy, and individual circumstances (dose, trimester, other health conditions) can affect the risk-benefit balance. This article does not recommend starting, stopping, or changing any medication without a personalized discussion with a treating clinician.

RatelHealth Bottom Line

Untreated depression and antidepressant treatment both carry potential risks during pregnancy, and current expert opinion emphasizes weighing both sides together rather than focusing on medication risk alone. Decisions about starting, continuing, or stopping SSRIs during pregnancy should always be made individually with a treating clinician — this article does not recommend any specific action.

Related Topics

Related reading: Major Depressive Disorder